Souvien Therapeutics
About:
Souvien Therapeutics is developing novel therapeutics to modulate critical epigenetic mechanisms associated with neurodegeneration.
Top Investors: Juvenescence
Description:
Souvien Therapeutics is a biotechnology company focused on developing therapeutic agents to modulate critical epigenetic mechanisms associated with neurodegeneration.
Total Funding Amount:
$3.5M
Headquarters Location:
Salt Lake City, Utah, United States
Founded Date:
Founders:
Number of Employees:
Last Funding Date:
2019-05-28
IPO Status:
Private
Industries:
© 2025 bioDAO.ai